Quarterly report pursuant to Section 13 or 15(d)

Intangibles, net - Summary Of The JMC Intangible Asset (Details)

v3.19.2
Intangibles, net - Summary Of The JMC Intangible Asset (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Dec. 31, 2018
Net intangible assets $ 971 $ 1,417
Journey Medical Corporation [Member]    
Finite-Lived Intangible Assets, Gross 2,800 2,800
Accumulated amortization (1,829) (1,383)
Net intangible assets $ 971 1,417
Ceracade [Member] | Journey Medical Corporation [Member]    
Finite-Lived Intangible Asset, Useful Life 3 years  
Finite-Lived Intangible Assets, Gross $ 300 300
Luxamend [Member] | Journey Medical Corporation [Member]    
Finite-Lived Intangible Asset, Useful Life 3 years  
Finite-Lived Intangible Assets, Gross $ 50 50
Targadox [Member] | Journey Medical Corporation [Member]    
Finite-Lived Intangible Asset, Useful Life 3 years  
Finite-Lived Intangible Assets, Gross $ 1,250 1,250
Exelderm [Member] | Journey Medical Corporation [Member]    
Finite-Lived Intangible Asset, Useful Life 3 years  
Finite-Lived Intangible Assets, Gross $ 1,200 $ 1,200